Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jul 2;15(7):1060.
doi: 10.3390/life15071060.

MMP-2-Potential Predictor of Epithelial-Mesenchymal Transition in Squamous Cell Carcinogenesis

Affiliations

MMP-2-Potential Predictor of Epithelial-Mesenchymal Transition in Squamous Cell Carcinogenesis

Doinița Temelie-Olinici et al. Life (Basel). .

Abstract

Epithelial-mesenchymal transition (EMT) is one of the key steps in cutaneous carcinogenesis. At the molecular level, this cellular dedifferentiation is modulated by the interaction of signalling pathways that favour basement membrane degradation under the influence of proinflammatory cytokines and matrix metalloproteinases (MMPs). Given the intricate role of these endopeptidases in modulating extracellular matrix turnover, the present study aimed primarily to identify the MMP-2 expression profile during the early stages of cutaneous malignant transformation. Forty-eight lesions with malignant transformation potential were excised in healthy tissue. Following the histopathological diagnosis of keratoacanthoma, Bowen's disease and actinic keratosis, the biological preparations were deparaffinised and homogenised in order to perform the FRET technique using the "MMP-2 Assay Kit Fluorometric". The results of the previous part of this research indicate that MMP-2 expression is more intense in lesions of actinic keratosis compared to normal tissues and to keratoacanthoma or Bowen's disease lesions, inversely proportional to the histopathological degree of dysplasia. Monitoring metalloproteinase activity in dysplastic epithelium may improve the detection of malignant transformation and guide treatment decisions.

Keywords: MMP-2; carcinogenesis; epithelial–mesenchymal transition; premalignant skin lesions.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Comparison of MMP-2 expression between lesions and epidermis witness controls.
Figure 2
Figure 2
Comparison of MMP-2 expression according to severity of dysplasia (degree of atypia).
Figure 3
Figure 3
Molecular controllers of EMT.

Similar articles

References

    1. Zou D.D., Sun Y.Z., Li X.J., Wu W.J., Xu D., He Y.T., Qi J., Tu Y., Tang Y., Tu Y.H., et al. Single-cell sequencing highlights heterogeneity and malignant progression in actinic keratosis and cutaneous squamous cell carcinoma. eLife. 2023;12:e85270. doi: 10.7554/eLife.85270. - DOI - PMC - PubMed
    1. Burstein S.E., Maibach H. Actinic keratosis metrics. Arch. Dermatol. Res. 2024;316:543. doi: 10.1007/s00403-024-03305-5. - DOI - PMC - PubMed
    1. Navarrete-Dechent C., Marghoob A.A., Marchetti M.A. Contemporary management of actinic keratosis. J. Dermatol. Treat. 2021;32:572–574. doi: 10.1080/09546634.2019.1682504. - DOI - PubMed
    1. Palaniappan V., Karthikeyan K. Bowen’s Disease. Indian Dermatol. Online J. 2022;13:177–189. doi: 10.4103/idoj.idoj_257_21. - DOI - PMC - PubMed
    1. Azimi A., Yang P., Ali M., Howard V., Mann G.J., Kaufman K.L., Fernandez-Penas P. Data Independent Acquisition Prote-omic Analysis Can Discriminate between Actinic Keratosis, Bowen’s Disease, and Cutaneous Squamous Cell Carcinoma. J. Investig. Dermatol. 2020;140:212–222. doi: 10.1016/j.jid.2019.06.128. - DOI - PubMed

LinkOut - more resources